Tetrabenazine Tablet
Product Images NDC 51407-480

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tetrabenazine (NDC 51407-480). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-480-12lb.jpg (51407 480 12lb)

51407-480-12lb.jpg (51407 480 12lb)
Tetrabenazine 12.5 mg tablets label from GSMS Incorporated, indicating 112 tablets per bottle. The label includes the NDC 51407-480-12, dosage strength, and advisory for pharmacists to dispense with the Medication Guide. Storage instructions specify maintaining the product between 20°C to 25°C with allowances from 15°C to 30°C.*
FDA Label Image

51407-481-12lb.jpg (51407 481 12lb)

51407-481-12lb.jpg (51407 481 12lb)
This is the packaging label for Tetrabenazine tablets, 25 mg strength, supplied in a package of 112 tablets. The label includes the NDC 51407-481-12 and indicates oral administration. It is labeled by Golden State Medical Supply, Inc. The label also notes storage instructions and cautions to keep out of reach of children and to use a tight container.*
FDA Label Image

Figure1.jpg (Figure1)

Figure1.jpg (Figure1)
A line graph showing chorea score change over study weeks comparing tetrabenazine and placebo. The x-axis represents study weeks from -1 to 14, and the y-axis shows chorea score change ranging from -7 to 1. The graph has two lines: tetrabenazine (solid line) showing a decrease in chorea scores over weeks 1 to 12, then a rise during washout, and placebo (dashed line) with a relatively stable score around -2. Error bars and participant numbers are included for each week.*
FDA Label Image

Figure2.jpg (Figure2)

Figure2.jpg (Figure2)
A line graph comparing the percentage of subjects achieving various points of change from baseline in Chronic Score between tetrabenazine and placebo treatment groups. The graph includes vertical reference lines at 3, 5, and 10 points change and a table summarizing the percentage of subjects in each group attaining changes in total chorea score at thresholds -10, 0, 5, and 10.*
FDA Label Image

Structure.jpg (Structure)

Structure.jpg (Structure)
Chemical structure of tetrabenazine showing a multi-ring system with two methoxy groups attached to a benzene ring and a side chain containing ketone and isopropyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.